AGADA Biosciences Overview

  • Founded
  • 2013

  • Status
  • Private

  • Employees
  • 20

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $297K

  • Investors
  • 4

AGADA Biosciences General Information


Provider of orphan drug development services. The company's service includes centralized preclinical drug efficacy testing and phenotyping services for neuromuscular disorders, with a specific expertise in murine models of duchenne muscular dystrophy. The company also provides clinical trial services, including patient muscle biopsy training and sample stewardship, biochemical assays on patient biopsies, and regulatory assistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1344 Summer Street
  • Suite 411
  • Halifax, Nova Scotia B3H 0A8
  • Canada
+1 (902) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGADA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 08-Jul-2019 $297K 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 000.00 Completed Generating Revenue
2. Accelerator/Incubator 21-Oct-2014 $23.4K $23.4K Completed Startup
1. Accelerator/Incubator Completed Startup
To view AGADA Biosciences’s complete valuation and funding history, request access »

AGADA Biosciences Executive Team (3)

Name Title Board Seat Contact Info
Eric Hoffman Ph.D Co-Founder, Chief Executive Officer & President
Amanda Mullen Chief Operating Officer
Kanneboyina Nagaraju Ph.D Co-Founder, President & Board Member
To view AGADA Biosciences’s complete executive team members history, request access »

AGADA Biosciences Board Members (1)

Name Representing Role Since
Kanneboyina Nagaraju Ph.D Self Co-Founder, President & Board Member 000 0000
To view AGADA Biosciences’s complete board members history, request access »

AGADA Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGADA Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Duchenne UK Corporation 000 0000 000000 0
BioNova Accelerator/Incubator 000 0000 000000 0
Global Business Accelerator Program Accelerator/Incubator 000 0000 000000 0
Innovacorp Venture Capital Minority 000 0000 000000 0
To view AGADA Biosciences’s complete investors history, request access »